Evolving Issues in Oncology
Susan M. Domchek, MD
JAMA. 2019;321(1):27. doi:10.1001/jama.2018.18942
This Viewpoint reviews the benefits and risks of risk-reducing mastectomy in otherwise healthy women with BRCA1 and BRCA2 mutations to inform discussions about the proceeding with or foregoing the procedure, and it calls for continued research to understand how to better individualize risk and prevent disease nonsurgically.
Sonoo Thadaney Israni, MBA; Abraham Verghese, MD
JAMA. 2019;321(1):29-30. doi:10.1001/jama.2018.19398
In this Viewpoint, Abraham Verghese and Sonoo Thadaney Israni acknowledge the promise of artificial intelligence (AI) for health care, but argue that developers must work with physicians to ensure that any AI health care system helps clinicians deliver better, more equitable humanistic care, not just more accurate, scientific care.
Audio Author Interview:
Humanizing Artificial Intelligence
Thomas M. Maddox, MD, MSc; John S. Rumsfeld, MD, PhD; Philip R. O. Payne, PhD
JAMA. 2019;321(1):31-32. doi:10.1001/jama.2018.18932
This Viewpoint discusses questions that should be addressed to successfully integrate artificial intelligence into clinical care.
Howard K. Koh, MD, MPH; Sara J. Singer, PhD, MBA; Amy C. Edmondson, PhD
JAMA. 2019;321(1):33-34. doi:10.1001/jama.2018.18935
In this Viewpoint, Howard Koh and colleagues discuss the value the public places on corporations that actively promote community health and environmental responsibility, and innovative business strategies that some corporations have implemented to advance consumer, employee, community, and environmental health.